Certara/CERT

$15.93

-1.72%
-
1D1W1MYTD1YMAX

About Certara

Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development in the global biopharmaceutical industry. It is focused on producing medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its customers include life sciences companies of all sizes along with contract research organizations, academic institutions, and global regulators. Its software and service are used by approximately 2,400 biopharmaceutical companies and academic institutions across 66 countries, including 38 of the top 40 biopharmaceutical companies. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, Netherlands, Philippines, Poland, Portugal, Spain, Switzerland, Egypt, and the United Kingdom.

Ticker

CERT

Sector

Technology

Trading on

NASDAQ

Industry

Software & Programming

CEO

William Feehery

Employees

1,338

Headquarters

Princeton, United States

Certara Metrics

BasicAdvanced
$2.72B
Market cap
-
P/E ratio
-$0.35
EPS
1.62
Beta
-
Dividend rate
$2.72B
1.6164
$24.96
$11.81
551.28K
2.616
27.532
27.821
1.03%
-3.53%
-5.21%
-3.81%
7.663
2.588
40.266
5.57%
-476.45%
13.32%

What the Analysts think about Certara

Analyst Ratings

Majority rating from 11 analysts.
Hold

Price Targets

Average projection from 9 analysts.
23.79% upside
High $23.00
Low $15.50
$15.93
Current price
$19.72
Average price target

Certara Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-14.09% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$88M
2.92%
Net income
$-12.4M
-74.64%
Profit margin
-14.09%
-75.36%

Certara Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 17.43%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.12
$0.12
$0.11
$0.09
-
Expected
$0.12
$0.13
$0.11
$0.11
$0.10
Surprise
-0.83%
-4.55%
0.92%
-17.43%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Certara stock?

Certara (CERT) has a market cap of $2.6B as of April 21, 2024.

What is the P/E ratio for Certara stock?

The price to earnings (P/E) ratio for Certara (CERT) stock is 0 as of April 21, 2024.

Does Certara stock pay dividends?

No, Certara (CERT) stock does not pay dividends to its shareholders as of April 21, 2024.

When is the next Certara dividend payment date?

Certara (CERT) stock does not pay dividends to its shareholders.

What is the beta indicator for Certara?

Certara (CERT) has a beta rating of 1.63. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Certara stock price target?

The target price for Certara (CERT) stock is $19.72, which is 23.79% above the current price of $15.93. This is an average based on projections from 9 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Certara stock

Buy or sell Certara stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing